Align Technology Non-GAAP EPS of $2.22 beats by $0.18, revenue of $1B beats by $9.2M
Align Technology press release (NASDAQ:ALGN): Q2 Non-GAAP EPS of $2.22  beats by $0.18.
Revenue of $1B (+3.1% Y/Y)  beats by $9.2M.
Q2'23 Clear Aligner revenues of $832.7 million, increased 5.4% sequentially and 4.3% year-over-year, and Clear Aligner volume of 604.4 thousand cases, increased 5.0% sequentially and 0.9% year-over-year
Q2'23 Clear Aligner volume for teens increased 7.0% sequentially and increased 9.7% year-over-year to 194.5 thousand cases
Q2'23 Imaging Systems and CAD/CAM Services revenues of $169.5 million, increased 10.5% sequentially.

Outlook: For Q3'23, we anticipate our WW Revenue to be in the range of $990M to $1,010M, up approximately 12% year-over-year at the midpoint.
We expect our Q3â23 GAAP and Non-GAAP operating margin to be slightly up from Q2'23, as we continue to strategically prioritize our investments in R&D and go-to-market activities to drive growth.
For full year 2023, assuming no circumstances occur that are beyond our control, we anticipate our 2023 WW Revenues to be in the range of $3.970B to $3.990B.
We also expect our full year 2023 GAAP operating margin to be slightly above 17% and our 2023 Non-GAAP operating margin to be slightly above 21%, a 1-point improvement from the guidance we provided in April 2023.
For 2023, we expect investments in capital expenditures to be approximately $200M. Capital expenditures are expected to primarily relate to building construction and improvements as well as manufacturing capacity in support of our continued international expansion.
Shares +12.11%.